Showing 2,581 - 2,600 results of 3,189 for search '"vaccine"', query time: 0.07s Refine Results
  1. 2581

    Immunological efficiency of Haemophilus influenzae type b polyribosyl ribitol phosphate combined with detoxified lipooligosaccharide in a rabbit model by Amin Arsang, Seyed Davar Siadat, Masoumeh Saberpour, Farshad Nojoomi

    Published 2025-02-01
    “… Background and Objectives: Haemophilus influenzae type b (Hib) could cause severe life-threatening infections in children. Combine vaccines have reduced invasive diseases, but disease management is still necessary. …”
    Get full text
    Article
  2. 2582

    EVALUATION OF POPULATION-LEVEL IMMUNITY TO SARS-COV-2 ACROSS BULGARIA (END OF 2023) by Kim Ngoc, Iva Trifonova, Teodora Gladnishka, Elitsa Panayotova, Evgenia Taseva, Vladislava Ivanova, Eleonora Kutevа, Iva Vladimirova, Iva Christova

    Published 2025-01-01
    “… Background: The COVID-19 pandemic in Bulgaria was characterized by a high mortality rate and vaccination efforts yielded suboptimal results. Understanding population immunity is important as new SARS-CoV-2 variants continue to emerge. …”
    Get full text
    Article
  3. 2583

    Caecal Perforation from Primary Intestinal Tuberculosis in Pregnancy by Soe Lwin, Nina Lau Lee Jing, Haris Suharjono, Mardiana binti Kipli, Tin Moe Nwe, Myat San Yi, Lucas Luk Tien Wee

    Published 2017-01-01
    “…The incidence of tuberculosis (TB) is rising worldwide, despite the efficacy of the BCG vaccination. Populations at greatest risk of contracting TB are migrant communities, as well as immunocompromised individuals. …”
    Get full text
    Article
  4. 2584

    A Case of Fulminant Meningococcemia: It Is All in the Complement by Kellie L. Hawkins, Mariah Hoffman, Sonia Okuyama, Sarah E. Rowan

    Published 2017-01-01
    “…As this new biologic agent becomes more widely prescribed, providers should be aware of the increased risk of meningococcemia. In addition to vaccination, providers may consider the use of oral penicillin for antibiotic prophylaxis against Neisseria meningitidis in these cases of functional complement deficiency.…”
    Get full text
    Article
  5. 2585

    Different types of control over epidemic processes of pasteurellosis and haemorrhagic septicemia by S. I. Dzhupina

    Published 2018-04-01
    “…Correspondingly, the control over pasteurellosis epidemic process is realized by satisfaction of animal needs by environmental conditions (dry bedding, satisfactory air exchange, time in the open air, etc.) and the control over haemorrhagic cepticemia epidemic process is realized by vaccination of production animals according to epizooto-logical showings and use of repellents and insecticides.…”
    Get full text
    Article
  6. 2586

    Modeling and analyzing the transmission dynamics of visceral leishmaniasis by Lan Zou, Jing Chen, Shigui Ruan

    Published 2017-09-01
    “…The basic reproduction number and sensitivity analysis show that the control of dog-sandfly transmission is more important for the elimination of the disease. Vaccination of susceptible dogs, treatment of infective dogs, as well as control of vertical transmission in dogs are effective prevention and control measures for visceral leishmaniasis.…”
    Get full text
    Article
  7. 2587

    Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies. by Peter R McIlroy, Le Thanh Mai Pham, Thomas Sheffield, Maxwell A Stefan, Christine E Thatcher, James Jaryenneh, Jennifer L Schwedler, Anupama Sinha, Christopher A Sumner, Iris K A Jones, Stephen Won, Ryan C Bruneau, Dina R Weilhammer, Zhuoming Liu, Sean Whelan, Oscar A Negrete, Kenneth L Sale, Brooke Harmon

    Published 2025-01-01
    “…Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to persist, demonstrating the risks posed by emerging infectious diseases to national security, public health, and the economy. Development of new vaccines and antibodies for emerging viral threats requires substantial resources and time, and traditional development platforms for vaccines and antibodies are often too slow to combat continuously evolving immunological escape variants, reducing their efficacy over time. …”
    Get full text
    Article
  8. 2588

    Attitudes of Final-Year Medical Students in Jordan Towards Volunteering During a Pandemic by Alassaf A, Gharaibeh L, Alkubaisi F, Alkhawaldeh M, Dababseh S, Odeh R

    Published 2025-01-01
    “…Around 60% of students were willing to participate in future voluntary work that does not involve patients infected with COVID-19, while 29.3% of them were willing to do so depending on the type of pandemic and the availability of vaccines. There were 86.1% of students who thought that participating in voluntary work involving infected patients during pandemics, should be optional; where 10.1% suggested that it should be compulsory if vaccines were available.Conclusion: The majority of medical students did not volunteer during the COVID 19 pandemic. …”
    Get full text
    Article
  9. 2589
  10. 2590

    One Health risk perception among the urban vulnerable dwellers of Gujarat, India: A cross-sectional assessment by Pratiksha Ganasva, Sandul Yasobant, Krupali Patel, Deepak Saxena

    Published 2024-12-01
    “…Another significant difference was observed in the perception on animal waste disposal sites with 58.9% of livestock keepers and 80.0% of non-livestock keepers considering such sites as risky factors (P=0.000). Furthermore, vaccination awareness was high, with 85.4% of livestock handlers and 88.7% of non-livestock handlers being aware of vaccination as a preventive measure against zoonotic diseases. …”
    Get full text
    Article
  11. 2591

    Impact of non-pharmacological interventions on the first wave of COVID-19 in Portugal 2020 by Dinis B. Loyens, Constantino Caetano, Carlos Matias-Dias

    Published 2025-02-01
    “…Introduction: The COVID-19 pandemic caused over 7 million global deaths. Without vaccines during the first wave, governments implemented nonpharmacological interventions (NPIs) such as lockdowns, school closures, and travel restrictions. …”
    Get full text
    Article
  12. 2592

    Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022. by Anna Bratcher, Jefferson M Jones, William A Meyer, Rehan Waheed, Huda Yazgi, Aaron Harris, Adi V Gundlapalli, Kristie E N Clarke

    Published 2025-01-01
    “…These individuals show weaker immunogenicity following vaccination than individuals without IC, yet immunogenicity after SARS-CoV-2 infection is poorly understood. …”
    Get full text
    Article
  13. 2593

    Arginase-1-specific T cells target and modulate tumor-associated macrophages by Mads Hald Andersen, Inés Lecoq, Ayako Wakatsuki Pedersen, Evelina Martinenaite, Shamaila Munir Ahmad, Maria Perez-Penco, Lucia Lara de la Torre, Marion Chapellier, Lars Rønn Olsen, Mia Aaboe-Jørgensen, Hannah Jorinde Glöckner, Anne Mette Askehøj Rømer

    Published 2025-01-01
    “…Tumor-conditioned media (TCM) derived from Arg1-vaccinated mice induced significantly higher upregulation of MHC-II on exposed myeloid cells compared with controls. …”
    Get full text
    Article
  14. 2594

    On application of optimal control to SEIR normalized models: Pros and cons by Maria do Rosário de Pinho, Filipa Nunes Nogueira

    Published 2017-01-01
    “…We use optimal control to control by vaccination the spread of a generic infectious disease described by a normalized model with $L^1$ cost. …”
    Get full text
    Article
  15. 2595

    Diagnosis and Management of Bacterial Meningitis in the Paediatric Population: A Review by Catherine L. Tacon, Oliver Flower

    Published 2012-01-01
    “…Over recent decades new vaccines have led to a change in epidemiology of the disease; however, it remains a condition that requires a high index of suspicion, prompt diagnosis, and early management in the emergency department. …”
    Get full text
    Article
  16. 2596

    New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma by Cong Luo, Xingxing Min, Danying Zhang

    Published 2025-01-01
    “…It involves recent immunotherapy advances, including monoclonal antibodies, tumor vaccines, immune cell therapies, checkpoint inhibitors, and oncolytic viruses, and discusses combining these with standard treatments.…”
    Get full text
    Article
  17. 2597
  18. 2598
  19. 2599

    Faktor Risiko yang Berhubungan dengan Kejadian Pneumonia pada Balita di Kelurahan Air Tawar Barat Padang by Yulia Efni, Rizanda Machmud, Dian Pertiwi

    Published 2016-08-01
    “…</em><em>5%), exposure to cigarette smoke (</em><em>74.1</em><em>%), a history of low birth weight (</em><em>3.7</em><em>%), did not get measles </em><em>vaccinations</em><em> (40</em><em>.</em><em>7%) and malnutrition (25</em><em>.…”
    Get full text
    Article
  20. 2600

    KLRB1 expression in nasopharyngeal mucosa as a prognostic biomarker in COVID-19 patients by Marilina García-Aranda, María Ángeles Onieva, Desirée Martín-García, Raúl Quirós, Inmaculada López, María Padilla-Ruiz, Teresa Téllez, Beatriz Martínez-Gálvez, María Luisa Hortas, Alberto García-Galindo, José González-Gomariz, Rubén Armañanzas, Francisco Rivas-Ruiz, Alfonso Serrano, Isabel Barragán-Mallofret, Maximino Redondo

    Published 2025-01-01
    “…While univariate analysis identified a significant association between KLRB1 expression and vaccination status (p < 0.05), only low KLRB1 expression (OR 1.135, 95% CI: 1.0-1.280), and age (OR 1.033, 95% CI: 1.006–1.061) were confirmed as independent risk factors for ICU admission or death, regardless of other studied variables such as comorbidities, vaccination status, or smoking habits. …”
    Get full text
    Article